Companies · Manufacturing

Cheribundi, Inc.

PORTLAND · Manufacturing

Diligence memoA one-page analyst read on Cheribundi, Inc. — recommendation, valuation, rhythm, risks.
$60.2M
Total raised · real
10
Rounds
0.2×
Latest step-up
Top 7%
Sector rank · raised
Series B
Latest stage · inferred · Wed May 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Cheribundi, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the manufacturing sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.02× the median modeled value of Series B Manufacturing companies in 2022–2024 (44 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.1 yr ago; this sector typically re-raises about every 12 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Manufacturing

Cheribundi, Inc. is one of 3256 Manufacturing companies tracked from PORTLAND. By capital raised it ranks among the largest (ahead of 94% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 504
Reg D exemption
4
Investors (latest)
2022-05-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2009-08-14 Raised $2.0M (real) Modeled valuation $24M (est)Seed2009Series A · 2011-07-01 Raised $5.0M (real) Modeled valuation $50M (est)Series A2011Series A · 2012-02-13 Raised $4.5M (real) Modeled valuation $45M (est)Series A2012Series A · 2013-11-22 Raised $1.3M (real) Modeled valuation $12M (est)Series A2013Series A · 2014-11-17 Raised $1.9M (real) Modeled valuation $19M (est)Series A2014Series A · 2016-03-01 Raised $4.6M (real) Modeled valuation $46M (est)Series A2016Series A · 2016-03-01 Raised $9.2M (real) Modeled valuation $92M (est)Series A2016Series A · 2016-03-01 Raised $4.6M (real) Modeled valuation $46M (est)Series A2016Series A · 2018-03-07 Raised $4.9M (real) Modeled valuation $49M (est)Series A2018Series A · 2018-03-08 Raised $10M (real) Modeled valuation $100M (est)Series A2018Series A · 2018-03-08 Raised $5.8M (real) Modeled valuation $58M (est)Series A2018Series A · 2019-10-17 Raised $14M (real) Modeled valuation $143M (est)Series A2019Series B · 2019-10-17 Raised $21M (real) Modeled valuation $232M (est)Series B2019Series B · 2021-03-11 Raised $5.0M (real) Modeled valuation $49M (est)Series B2021Seed · 2021-03-11 Raised $1.3M (real) Modeled valuation $13M (est)Seed2021Series B · 2022-05-18 Raised $235K (real) Modeled valuation $1.9M (est)Series B2022Cumulative $96M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2009
Series A$5.0M · 2011
Series A extension$4.5M · 2012
Series A extension$1.3M · 2013
Series A extension$1.9M · 2014
Series A extension$4.6M · 2016
Series A extension$9.2M · 2016
Series A extension$4.6M · 2016
Series A extension$4.9M · 2018
Series A extension$10.0M · 2018
Series A extension$5.8M · 2018
Series A extension$14.3M · 2019
Series B$21.1M · 2019
Series B extension$5.0M · 2021
Bridge · Series B-stage$1.3M · 2021smaller follow-on
Series B extension$235K · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$1.9M
Base estimate est.
$599K
Conservative case
$5.0M
Upside case
$1.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the manufacturing sector profile. Directional, not a quoted figure.

Seed · modeled $24.0M · 2009-08-142009Series A · modeled $49.9M · 2011-07-01Series A · modeled $44.9M · 2012-02-13Series A · modeled $12.5M · 2013-11-22Series A · modeled $19.0M · 2014-11-17Series A · modeled $46.0M · 2016-03-01Series A · modeled $91.8M · 2016-03-01Series A · modeled $46.0M · 2016-03-01Series A · modeled $49.4M · 2018-03-07Series A · modeled $99.9M · 2018-03-08Series A · modeled $57.9M · 2018-03-08Series A · modeled $142.7M · 2019-10-17Series B · modeled $231.8M · 2019-10-17Series B · modeled $48.6M · 2021-03-11Seed · modeled $13.0M · 2021-03-11Series B · modeled $1.9M · 2022-05-182022
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
69%
Survival probability
46% low · 85% high
1.19×/yr
Annual markup
1.44×/yr upside case
4.1 yr
Elapsed time used
4.1 yr actual, capped for stale marks
manufacturing
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
10 mo
Avg between rounds
$4.7M/yr
Capital velocity
16.9 yr
On record since
2009
First round
16
Rounds on file
How it compares to the market

Benchmarked against 3256 companies in Manufacturing. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 30× above median
This company$60.2M
Sector median$2.0M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.0× of median
This company$235K
Sector median$18.5M
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$1.9M
Sector median$12.0M

Raised more than 94% of sector peers (real $). Modeled value above 13% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #42 of 44.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Stryve Foods, Inc. · Series B Raised $35.0M · modeled $294.5M (est)JW Rutledge Distillery, LLC · Series B Raised $34.0M · modeled $276.2M (est)Orange EV LLC · Series B Raised $35.0M · modeled $267.7M (est)Brondell Inc. · Series B Raised $28.6M · modeled $229.9M (est)Advantest Corp · Series B Raised $26.1M · modeled $204.7M (est)Endera Corp · Series B Raised $55.9M · modeled $200.8M (est)Goldback Inc. · Series B Raised $35.0M · modeled $197.3M (est)Trade Secret Chocolates, LLC · Series B Raised $32.1M · modeled $177.1M (est)VGI Plastics Sub Acquisition Company, LLC · Series B Raised $22.3M · modeled $163.9M (est)Lemurian, Inc. · Series B Raised $33.0M · modeled $158.1M (est)Selkirk Pharma, Inc. · Series B Raised $82.1M · modeled $152.6M (est)Xos, Inc. · Series B Raised $20.0M · modeled $151.9M (est)Cheribundi, Inc. (this company) Raised $60.2M · modeled $1.9M (est)Cheribundi, Inc.
CompanyStageRaised · realValue · estvs peer med.
Stryve Foods, Inc.Series B$35.0M$294.5M2.64×
JW Rutledge Distillery, LLCSeries B$34.0M$276.2M2.47×
Orange EV LLCSeries B$35.0M$267.7M2.40×
Brondell Inc.Series B$28.6M$229.9M2.06×
Advantest CorpSeries B$26.1M$204.7M1.83×
Endera CorpSeries B$55.9M$200.8M1.80×
Goldback Inc.Series B$35.0M$197.3M1.77×
Trade Secret Chocolates, LLCSeries B$32.1M$177.1M1.58×
VGI Plastics Sub Acquisition Company, LLCSeries B$22.3M$163.9M1.47×
Lemurian, Inc.Series B$33.0M$158.1M1.41×
Selkirk Pharma, Inc.Series B$82.1M$152.6M1.37×
Xos, Inc.Series B$20.0M$151.9M1.36×
Cheribundi, Inc. this companySeries B$60.2M$1.9M0.02×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2009-08-14$9.8M$24.0M85%
Series A$5.0M2011-07-01$22.7M$49.9M85%
Series A$4.5M2012-02-13$20.5M$44.9M85%
Series A$1.3M2013-11-22$5.7M$12.5M85%
Series A$1.9M2014-11-17$8.6M$19.0M85%
Series A$4.6M2016-03-01$21.0M$46.0M90%
Series A$9.2M2016-03-01$41.8M$91.8M90%
Series A$4.6M2016-03-01$21.0M$46.0M85%
Series A$4.9M2018-03-07$22.5M$49.4M90%
Series A$10.0M2018-03-08$45.5M$99.9M90%
Series A$5.8M2018-03-08$26.3M$57.9M90%
Series A$14.3M2019-10-17$64.9M$142.7M90%
Series B$21.1M2019-10-17$117.4M$231.8M90%
Series B$5.0M2021-03-11$27.8M$48.6M90%
Seed$1.3M2021-03-11$6.5M$13.0M90%
Series B$235K2022-05-18$1.3M$1.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2009-08-14
    • First recorded raise — entered as Seed.
    • 32 investors on this round.
  2. Series A$5.0M2011-07-01
    • Raised again after 23 mo — slower than the ~12 mo sector norm.
    • Round 2.6× larger than the prior — scaling up.
  3. Series A$4.5M2012-02-13
    • Raised 7 mo later, in step with the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 32 investors on this round.
  4. Series A$1.3M2013-11-22
    • Raised again after 21 mo — slower than the ~12 mo sector norm.
    • Round 3.6× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 5 investors on this round.
  5. Series A$1.9M2014-11-17
    • Raised 12 mo later, in step with the ~12 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 2 investors on this round.
  6. Series A$4.6M2016-03-01
    • Raised 15 mo later, in step with the ~12 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
    • 12 investors on this round.
  7. Series A$9.2M2016-03-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • 21 investors on this round.
  8. Series A$4.6M2016-03-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 12 investors on this round.
  9. Series A$4.9M2018-03-07
    • Raised again after 24 mo — slower than the ~12 mo sector norm.
    • Round roughly the size of the prior one.
    • 11 investors on this round.
  10. Series A$10.0M2018-03-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× larger than the prior — scaling up.
    • 43 investors on this round.
  11. Series A$5.8M2018-03-08
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 14 investors on this round.
  12. Series A$14.3M2019-10-17
    • Raised again after 19 mo — slower than the ~12 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • 3 investors on this round.
  13. Series B$21.1M2019-10-17
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.5× larger than the prior — scaling up.
    • 3 investors on this round.
  14. Series B$5.0M2021-03-11
    • Raised 17 mo later, in step with the ~12 mo sector norm.
    • Round 4.2× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  15. Seed$1.3M2021-03-11
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.8× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  16. Series B$235K2022-05-18
    • Raised 14 mo later, in step with the ~12 mo sector norm.
    • Round 5.5× smaller than the prior — bridge or down round.
    • Switched to Rule 504 (was Rule 506(b)).
    • 4 investors on this round.
Intelligence
2023 ~Q1
Modeled next raise · ~10mo cadence
$235K
Modeled next size est.range $235K$376K
0.2×
Last step-up
$4.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Andreas Guldin8 other2013-11
Marcel Bens7 other2019-10
Zachary Shulman6 other2013-11
John Shields5 other2012-02
Zachary J. Shulman5 other2011-07
Brian Ross2 other2011-07
John J. Shields2 other2011-07
Scott Roman2 other2018-03
Hans Heer1 other2013-11
Morgan Ratcliffe1 other2019-10
Andreas J. Guldin2012-02
Ben Fineberg2019-10
Bill Brophy2018-03
Brittany J. Ridley2011-07
Brittany Ridley2012-02
Carol P. Langdon2009-08
Christopher L. Shoemaker2009-08
Christopher Shoemaker2011-07
Donald S. Copland2009-08
Edmund J. Maguire2016-03
Edmund Maguire2013-11
James J. O'Callaghan2016-03
James O'Callaghan2016-03
Michael Oringer2013-11
Registry & provenance

Cheribundi, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1432835
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Ioxus, Inc.Other EnergySeries B$71.1M$23.2Mnetwork2 shared operators · same stage
Primet Precision Materials IncManufacturingSeries A$9.6M$30.0Mnetwork2 shared operators · same sector
Tcho Ventures IncManufacturingSeries A$4.2M$42.1Mnetwork2 shared operators · same sector
Neochord IncManufacturingSeries B$78.2M$2.4Msame sector · same stage
Prolacta Bioscience IncBiotechnologySeries B$64.7M$353.6Mnetwork1 shared operator · same stage
OLEDWorks LLCManufacturingSeries B$82.6M$1.6Msame sector · same stage
EverQuote, Inc.Other TechnologySeries B$52.4M$255.9Mnetwork1 shared operator · same stage
Vestmark IncOther TechnologySeries B$43.6M$354.8Mnetwork1 shared operator · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Peachicana Products Inc.ManufacturingPre-Seed$15.3M81%
Rubi Laboratories, Inc.ManufacturingSeries A$22.0M80%
StanChem Holdings, LLCManufacturingSeries B$167.7M80%
GFBC, Inc.ManufacturingSeries A$128.8M79%
Klaris, Inc.ManufacturingPre-Seed$2.8M79%
GoSili, Inc.ManufacturingPre-Seed$4.6M79%
Sonmundo, Inc.ManufacturingSeed$6.1M78%
FyberX Holding, LLCManufacturingSeed$3.6M78%
Frequently asked
How much funding has Cheribundi, Inc. raised?
Cheribundi, Inc. has raised approximately $60.2M in disclosed capital across 10 recorded financing rounds, aggregated from public filings.
What is Cheribundi, Inc.'s estimated valuation?
Provath's modeled valuation for Cheribundi, Inc. is approximately $1.9M (modeled range $599K–$5.0M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Cheribundi, Inc. at?
Cheribundi, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Wed May 18.
What does Cheribundi, Inc. do and where is it based?
Cheribundi, Inc. operates in the Manufacturing sector, based in PORTLAND.
Explore related

See where Cheribundi, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Cheribundi, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.